1407 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
RSS Create an RSS feed from your search for:
"Sexually Transmitted Diseases, Viral"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
2 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
3 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
4 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
5 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
6 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
7 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
8 Completed A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules
Condition: HIV Infections
Intervention: Biological: gp160 Vaccine (Immuno-AG)
9 Terminated An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
Conditions: Herpes Zoster;   Neuralgia;   Pain;   HIV Infections;   Peripheral Nervous System Diseases;   Diabetic Neuropathies;   Diabetes Mellitus;   Polyneuropathies
Intervention: Drug: Capsaicin Dermal Patch
10 Completed The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Zidovudine;   Drug: Didanosine
11 Completed
Has Results
Combination Pain Therapy in HIV Neuropathy
Conditions: HIV Infections;   Peripheral Neuropathy
Interventions: Drug: Duloxetine;   Drug: Duloxetine placebo;   Drug: Methadone;   Drug: Methadone placebo
12 Completed Predictors of Antiretroviral Pharmacokinetics in HIV-infected Women With Virologic Suppression
Condition: Human Immunodeficiency Virus
Intervention:
13 Completed Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)
Condition: HIV Infection
Interventions: Drug: Tenofovir (TDF);   Drug: Emtricitabine (FTC);   Drug: Efavirenz (EFV)
14 Completed Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
Conditions: AIDS Dementia Complex;   HIV Infections
Interventions: Drug: Zidovudine;   Drug: Didanosine
15 Completed SPL7013 Gel - Male Tolerance Study
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Drug: 3% w/w SPL7013 Gel (VivaGel™)
16 Terminated Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.
Condition: HIV Infections
Intervention: Drug: ACH126-443 (Beta-L-Fd4C)
17 Completed Relative Bioavailability Study of GSK1265744 Formulations
Condition: Infections, Human Immunodeficiency Virus and Hepatitis
Interventions: Drug: GSK1265744 Na Salt Tablets;   Drug: GSK1265744 Free Acid Nanomilled Capsules;   Drug: GSK1265744 Free Acid Micronized Capsules
18 Completed The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms
Condition: HIV Infections
Interventions: Drug: HBY 097;   Drug: Zidovudine
19 Completed Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
Conditions: Fracture;   Infection, Human Immunodeficiency Virus
Interventions: Other: No Antiretroviral (ARV) Drug Exposure;   Drug: Any Antiretroviral (ARV) Drug Exposure
20 Completed Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: Nevirapine;   Drug: Zidovudine;   Drug: 3TC

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years